Saint Louis University, Saint Louis, MO. RATIONALE: Oral immunotherapy (OIT) for foods is safe and effective. Standard OIT regimens for peanut start with protein doses in the microgram range, but many patients fail peanut food challenges after consuming large amounts of peanut protein and are good candidates for modified protocols. METHODS: We performed a retrospective chart review to identify patients seen between July 2016 and August 2018 who failed peanut challenges and chose to start a modified OIT protocol at < _25% of the failed dose the day after the challenge. RESULTS: Forty patients were identified ranging in age from 7 months to 18 years with a median age of 23 months. Initial OIT doses ranged from 2mg to 1167mg with a mean dose of 204mg peanut protein. Fourteen patients have completed peanut OIT and are on a maintenance daily dose of at least 2 teaspoons peanut butter (2334mg peanut protein). Twenty-six patients are in the dose escalation phase. Initial total peanut and Ara h 2 IgE values ranged from 0.1 to 34.3kU/L and 0.12 to 16.2kU/L, respectively. Seven patients (17.5%) were treated with epinephrine during challenges, but no patients have required epinephrine during the OIT process. CONCLUSIONS: Initiating a modified OIT regimen at ;25% of the failed dose the day after a peanut challenge should be considered in patients without a previous history of anaphylaxis, even those with significant levels of IgE to Ara h 2. This may be of particular benefit to young children with a history of mild reactions to peanut. Little is known about outcome of individually customized OIT in children with mild to moderate peanut allergy. METHODS: Medical records of children who received OIT from one allergist in an academic practice (ML) were reviewed for history and outcome of OIT. RESULTS: 129 Children received OIT from 2012-18, with 101 receiving peanut OIT alone and 28 peanut with other foods. Peanut butter was used; starting dose was individually customized by last dose tolerated historically or through oral food challenge (OFC), and maintenance dose ranged from 1 to 2 teaspoons peanut butter (or 8 to 16 peanuts). Of the 101 children, 53 are on daily maintenance, 17 are still updosing, 12 discontinued or were lost to follow up, 19 completed OIT and are consuming serving-size amounts of peanut 2-3 times weekly or ad lib. They are not avoiding peanut in their diet otherwise. Of the 19 completers, reactions to pre-OIT peanut OFC were mild in 13, moderate in 4. Duration of OIT was (mean6SD)1.0560.4 years. At start of OIT, age was 5.362.6 years, peanut serum IgE1.1560.9 KU/L and peanut prick skin test wheal14.2568.9 mm, which decreased to 0.860.6 KU/L and 5.0763.2 mm, respectively, at end of OIT. CONCLUSIONS: In an average of one year, OIT using peanut butter or plain peanuts in an individually customized dosing in children with mild to moderate peanut allergy resulted in long term tolerance with decreased sensitization.
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The assessment of clinical and laboratory findings before and after oral immunotherapy to egg white The patients with a history of allergic reaction and positive skin prick test (SPT) to egg white as well as the inability to pass the Oral Food Challenge (OFC) were selected. Eight patients underwent OIT for egg white during 6 months while controls avoided to consume egg white. The SPT, the assessment of specific IgE and IgG4 were performed before and after OIT. RESULTS: After 6 months OIT, all patients of OIT group were able to tolerate 40 cc pasteurized raw egg white while none of the control group was able to pass the challenge. A significant difference in wheal size to egg white was found before and after OIT in OIT group (P50.01) as well as in comparison with control group (P50.02). The results revealed significant decrease in specific IgE to egg white (P50.01) as well as increase of specific IgG4 to egg white although insignificantly. Moreover, IgE/IgG4 ratio to egg white was 0.44 versus 0.12 (P50.01). CONCLUSIONS: Since all patients in OIT group continued 6 months follow up and nobody left the study due to side effects of therapeutic process, this method could be considered as a promising and safe method to treat food allergies.
